SCHEDULE: Armistice Capital Boosts Treace Medical Stake to 9.91%

Armistice Capital and Steven Boyd have increased their beneficial ownership in Treace Medical Concepts, Inc. to 9.91% of common stock.

Summary

• Armistice Capital, LLC and Steven Boyd are the reporting persons in this Schedule 13G/A filing.
• They collectively beneficially own 6,260,000 shares of Treace Medical Concepts, Inc. common stock.
• This ownership represents 9.91% of the company's total outstanding common stock.
• The percentage is calculated based on 63,173,126 shares of common stock outstanding as of July 31, 2025, as reported in the Issuer's Form 10-Q filed on August 7, 2025.
• The shares are held in the ordinary course of business and were not acquired for the purpose or with the effect of changing or influencing the control of the issuer.

Sentiment

Score: 6

Explanation: The filing indicates an increased stake by a significant institutional investor, which can be interpreted as a vote of confidence, though the filing itself is purely a factual ownership disclosure and does not contain performance or strategic updates.

Positives

• A significant institutional investor, Armistice Capital, LLC, and its managing member, Steven Boyd, have increased their stake in Treace Medical Concepts, Inc.
• Their beneficial ownership now stands at 9.91%, indicating a notable and substantial position in the company.

Future Outlook

N/A

Management Comments

• Shares were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

This filing is a disclosure of beneficial ownership by an investment firm and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: Increased institutional ownership by Armistice Capital and Steven Boyd may signal confidence in the company's prospects, potentially influencing investor sentiment.

Key Dates

Keywords

Treace Medical Concepts, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Investment, SEC Filing